Professional Documents
Culture Documents
irreversible damage. The essential point of this definition is that postischemic dysfunction, no matter
how severe or prolonged, is a fully reversible abnormality. Diagnosis of myocardial stunning should not
be made unless reasonable assurance can be provided that the tissue in question is still entirely
viable.
In accordance with this definition, myocardial
stunning is a relatively mild, sublethal injury that must
be kept quite distinct from myocardial infarction. It is
unknown whether these two conditions share a common mechanism. Consequently, this review will discuss only results obtained in experimental preparations in which mechanical dysfunction is likely to be
due to stunning rather than to cell death. The
mechanism of lethal ischemia-reperfusion injury has
been reviewed previously2-7 and is beyond the scope
of this article.
Classification of Myocardial Stunning
Experimentally, the concept of myocardial stunning encompasses a wide variety of settings with
major pathophysiological differences. A classification
is in order because different mechanisms have been
described in different experimental conditions. The
available observations can be grouped into the fol-
724
TABLE 1. Classification of Myocardial Stunning and Evidence for Various Mechanisms Proposed in Experimental Animals
Evidence for pathogenetic role of:
Reduced
Sarcoplasmic
Damage of
reticulum
Calcium
calcium
Oxygen
collagen
radicals
overload
Experimental setting
dysfunction
matrix
sensitivity
Stunning due to decreased blood flow
Regional ischemia
One completely reversible ischemic
++
?
episode
Multiple completely reversible
+
+
?
ischemic episodes
+
One partly irreversible ischemic
?
?
?
episode (subendocardial infarction)
Global ischemia
+
+
+
Isolated heart in vitro
?
+
?
?
?
?
Cardioplegic arrest in vivo
Stunning due to increased 02 demands
Exercise-induced ischemia
?
+, Published studies support this mechanism; + +, published studies from multiple laboratories consistently support this mechanism, and
evidence is also available in conscious animal preparations; -, published studies do not support this mechanism; , published studies are
conflicting; ?, no data are available.
725
disrupt normal energy use and thus have been postulated to contribute to postischemic dysfunction.68
This hypothesis, however, appears implausible
because it does not explain the considerable contractile and metabolic reserve of the stunned myocardium.17'30'61-66 Indeed, the reversal of postischemic dysfunction by inotropic stimuli implies that the
residual activity of myofibrillar creatine kinase is still
sufficient to run the myofibrillar ATPase reaction at
normal or supranormal rates.
Impairment of Sympathetic Neural Responsiveness
After 25 minutes of coronary occlusion, the reperfused myocardium loses its inotropic responsiveness
to sympathetic nervous stimulation, suggesting injury
to the sympathetic-neural axis.69 However, no such
defect is observed after 15 minutes of coronary
occlusion.70 Furthermore, as noted above, myocardial stunning occurs in isolated (and thereby denervated) hearts. Although functional sympathetic denervation may contribute to postischemic dysfunction
in certain situations in which contractility is strongly
dependent on sympathetic drive, it seems unlikely
that this abnormality plays a major role in most
experimental preparations of myocardial stunning.
726
727
728
729
in the genesis of myocardial stunning after a 15minute period of ischemia, in both open-chest and
conscious animals. The relative contributions of the
various metabolites have not been definitively established. It is clear that a portion of the damage is
mediated by OH; however, the available evidence
suggests that myocardial stunning cannot be simplistically ascribed to a single oxygen species and that all
of the three initial metabolites of oxygen (02 , H202
and *OH) contribute to the cellular injury responsible
for postischemic dysfunction. Iron also appears to
play a role in stunning, presumably by catalyzing the
formation of OH.
Direct evidence for the oxyradical hypothesis. A
major limitation of the studies reviewed heretofore50,57,97-99,103-107,110 is that all of the evidence provided by these investigations is indirect and therefore
inconclusive. Clearly, to definitively confirm a causative role of oxygen metabolites in postischemic
dysfunction, it is necessary to directly demonstrate
and quantitate free radical generation in the stunned
myocardium in the presence and absence of antioxidant interventions.
Production of free radicals has been directly
demonstrated in isolated rabbit or rat hearts undergoing global ischemia and reperfusion,42,4311-113
but because of the numerous important differences
in experimental conditions, results obtained in vitro
cannot necessarily be extrapolated to the intact
animal. We used the spin trap a-phenyl N-tert-butyl
nitrone (PBN) and electron paramagnetic resonance (EPR) spectroscopy to detect and measure
production of free radicals in our in vivo model of
postischemic dysfunction (15-minute coronary
occlusion in open-chest dogs).14 After infusion of
PBN, EPR signals characteristic of PBN radical
adducts were detected in the venous blood draining
from the ischemic-reperfused vascular bed.15 The
EPR signals were consistent with a mixture of
different secondary lipid radicals, such as alkyl and
alkoxy radicals. The myocardial production of radicals began during coronary occlusion but increased
dramatically after reperfusion, peaking at 2-4 minutes. After this initial burst, production of radicals
abated but did not cease, persisting for as long as 3
hours after reflow.1" There was a linear, positive
relation between the magnitude of adduct production and the magnitude of ischemic flow reduction,
indicating that the intensity of free radical generation after reflow is determined by the severity of the
antecedent ischemia"15-the greater the degree of
hypoperfusion, the greater the subsequent production of free radicals and, by inference, the severity
of reperfusion injury. These findings imply that
interventions that improve perfusion during ischemia will attenuate free radical reactions after
abnormalities.
In summary, it is clear that reactive oxygen species
depress myocardial contractility both in vitro and in
vivo. The precise role of each species remains to be
defined. There is considerable evidence that the
detrimental effects of *2- and H202 on cardiac
730
731
732
Clinical Implications
There are numerous clinical settings in which the
myocardium is subjected to transient ischemia,
including unstable or variant angina, acute myocardial infarction with early reperfusion (either spontaneous or induced by thrombolytic therapy), openheart surgery with cardioplegic arrest, and cardiac
transplantation. Recent observations suggest that
these situations may be associated with myocardial
stunning, which may be an important factor precipitating left ventricular failure with its attendant morbidity and mortality.1,166 Furthermore, in patients in
whom silent episodes of ischemia recur at short
intervals in the same territory, the myocardium might
remain reversibly depressed for prolonged periods of
time or even chronically.1 Elucidation of the mechanism responsible for postischemic dysfunction is
indispensable for developing effective clinical therapies. The evidence discussed herein implies that
myocardial stunning could be effectively attenuated
by pharmacological manipulations targeted at specific pathogenetic mechanisms, for example, by
antioxidant agents given before reperfusion. Compared with standard treatments for cardiac failure
such as inotropic stimulation, antioxidants represent
a novel approach; by interfering with the mechanism
of cell injury, they might prevent rather than simply
temporarily correct postischemic dysfunction. This
approach also appears desirable because it is uncertain whether prolonged inotropic stimulation of
stunned myocardium has deleterious effects.
733
Ja+
IN
rload
over
,
? t Reducing equivalents
Xanthine oxidase ?
* *-? tMitochondrial "univalent leak"
eutrophil activation ?
"
? Autoxidative processes
Arachidonate cascade ? -SOD
_
*0 2
H2 2
I
FeFI1
*OH
Enzyme inactivation
.u
KhhO
Lipid peroxidation
Damage of:|
/"
<eofjj t
? SARCOPLASMIC
*****K
? OTHER S TRUCTURES
or COLLAGEN
MATRIX)
? SARCOLEMMA
RETICULUM
(e.g., CONTRACTIIILE
PROTEINSS
'Ca+" overload
+ f+
f
Excitation-contraction uncoupling-
I Sensitivity
to Ca++
..~
L.IMECHANICAL DYSFUNCTION
Loss of
mechanical
coupling
m
FIGURE 1. Proposed pathogenesis of postischemic myocardial dysfunction. This proposal integrates and reconciles different
mechanisms into a unifyingpathogenetic hypothesis. Transient reversible ischemia followed by reperfusion could result in increased
production of superoxide radicals (02 ) through several mechanisms, including 1) increased activity of xanthine oxidase, 2)
activation of neutrophils, 3) activation of arachidonate cascade, 4) accumulation ofreducing equivalents during oxygen deprivation,
5) derangements of intramitochondrial electron transport system resulting in increased univalent reduction of oxygen, and 6)
autoxidation of catecholamines and other substances. Superoxide dismutase (SOD) dismutates '02- to hydrogen peroxide (H202);
in the presence of catalytic iron, '02- and 11202 interreact in a Haber- Weiss reaction to generate the hydroxyl radical (.OH). H202
can also generate *OH in the absence of '02 through a Fenton reaction provided that other substances (such as ascorbate) reduce
Fe (III) to Fe (II). '02- and OH attack proteins and polyunsaturated fatty acids, causing enzyme inactivation and lipid
peroxidation, respectively. In reversible ischemia, the intensity of this damage is not sufficient to cause cell death but is sufficient to
produce dysfunction ofkey cellular organelles. Postulated targets offree radical damage include 1) the sarcolemma, with consequent
loss of selective permeability, impairment of calcium-stimulated ATPase activity and calcium transport out of the cell, and
impairnent of Na+K+-ATPase activity (the net result of these perturbations would be increased transarcolemmal calcium influx
and cellular calcium overload); 2) the sarcoplasmic reticulum, with consequent impairment of calcium-stimulated A TPase activity
and calcium transport (this would result in impaired calcium homeostasis- specifically, decreased calcium sequestration, which
would contribute to increase free cytosolic calcium, and decreased calcium release during systole, which would cause
excitation-contraction uncoupling); and 3) possibly other structures, such as the extracellular collagen matrix (with consequent loss
of mechanical coupling) or the contractile proteins (with consequent decreased sensitivity to calcium). At the same time, reversible
ischemia-reperfusion could cause cellular Na+ overload due to 1) inhibition of sarcolemmal Na+,K+-ATPase and 2) acidosis and
Na+-H+ exchange. This could further exaggerate calcium overload by increased Na +-Ca2' exchange. An increase in free cytosolic
calcium would activate phospholipases and other degradative enzymes and further exacerbate the injury to the aforementioned key
subcellular structures (sarcolemma, sarcoplasmic reticulum, and contractile proteins). Thus, calcium overload could serve to
amplify the damage initiated by oxygen radicals. In addition, calcium overload could in itself impair contractile performance and
contribute to mechanical dysfunction. It is also possible that the increase in free cytosolic calcium could increase oxyradical
production bypromoting conversion ofxanthine dehydrogenase to xanthine oxidase. The ultimate consequence of this complex series
ofperturbations is a reversible depression of contractility.
Summary
Among the numerous mechanisms proposed for
myocardial stunning, three appear to be more plausible: 1) generation of oxygen radicals, 2) calcium
overload, and 3) excitation-contraction uncoupling.
First, the evidence for a pathogenetic role of
oxygen-derived free radicals in myocardial stunning
is overwhelming. In the setting of a single 15-minute
coronary occlusion, mitigation of stunning by antioxidants has been reproducibly observed by several
independent laboratories. Similar protection has
been recently demonstrated in the conscious animal,
that is, in the most physiological experimental preparation available. Furthermore, generation of free
radicals in the stunned myocardium has been directly
demonstrated by spin trapping techniques, and atten-
734
Acknowledgment
The excellent secretarial assistance of William
LaCour is gratefully acknowledged.
References
1. Braunwald E, Kloner RA: The stunned myocardium: Prolonged, postischemic ventricular dysfunction. Circulation
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
1982;66:1146-1149
2. Jennings RB, Reimer KA: Factors involved in salvaging
3.
4.
5.
6.
7.
8.
24.
25.
26.
28.
29.
30.
31.
32.
33.
34.
35.
36.
37.
38.
39.
40.
41.
42.
43.
44.
45.
consequence of reperfusion-induced cellular calcium overload in ferret hearts. J Clin Invest 1987;79:950-961
Steenbergen C, Murphy E, Levy L, London RE: Elevation in
cytosolic free calcium concentration early in myocardial
ischemia in perfused rat heart. Circ Res 1987;60:700-707
Porterfield JK, Kusuoka H, Weisman HF, Weisfeldt ML,
Marban E: Ryanodine prevents the changes in myocardial
function and morphology induced by reperfusion after brief
periods of ischemia (abstract). Circ Res 1987;35:315A
Ambrosio G, Jacobus WE, Bergman CA, Weisman HF,
Becker LC: Preserved high energy phosphate metabolic
reserve in globally "stunned" hearts despite reduction of
basal ATP content and contractility. J Mol Cell Cardiol
1987;19:953-964
Kitakaze M, Weisfeldt ML, Marban E: Acidosis during early
reperfusion prevents myocardial stunning in perfused ferret
hearts. J Clin Invest 1988;82:920-927
Kusuoka H, Koretsune Y, Chacko VP, Weisfeldt ML, Marban E: Excitation-contraction coupling in postischemic myocardium: Does failure of activator Ca21 transients underlie
stunning? Circ Res 1990;66:1268-1276
Ambrosio G, Jacobus WE, Mitchell MC, Litt MR, Becker
LC: Effects of ATP precursors on ATP and free ADP content
and functional recovery of postischemic hearts. Am J Physiol
1989;256:H560-H566
Marban E, Koretsune Y, Corretti M, Chacko VP, Kusoka H:
Calcium and its role in myocardial cell injury during ischemia
and reperfusion. Circulation 1989;80(suppl IV):IV-17-IV-22
Schlafer M, Kane PF, Kirsh MM: Superoxide dismutase plus
catalase enhances the efficacy of hypothermic cardioplegia to
protect the globally ischemic, reperfused heart. J Thorac
Cardiovasc Surg 1982;83:830-839
Shlafer M, Kane PF, Wiggins VY, Kirsh MM: Possible role
for cytotoxic oxygen metabolites in the pathogenesis of
cardiac ischemic injury. Circulation 1982;66(suppl I):I-85I-92
Casale AS, Bulkley GB, Bulkley BH, Flaherty JT, Gott VL,
Gardner TJ: Oxygen free radical scavengers protect the
arrested globally ischemic heart upon reperfusion. Surg
Forum 1983;34:313-316
Menasche P, Grousset C, Gauduel Y, Piwnica A: A comparative study of free radical scavengers in cardioplegic solutions: Improved protection with peroxidase. J Thorac Cardiovasc Surg 1986;92:264-271
Myers CL, Weiss SJ, Kirsh MM, Shepard BM, Shlafer M:
Effects of supplementing hypothermic crystalloid cardioplegic solution with catalase, superoxide dismutase, allopurinol,
or deferoxamine on functional recovery of globally ischemic
and reperfused isolated hearts. J Thorac Cardiovasc Surg
1986;91:281-289
Ambrosio G, Weisfeldt ML, Jacobus WE, et al: Evidence for
a reversible oxygen radical-mediated component of reperfusion injury: Reduction by recombinant human superoxide
dismutase administered at the time of reflow. Circulation
1987;75:282-291
Ytrehus K, Gunnes S, Myklebust R, Mjos OD: Protection by
superoxide dismutase and catalase in the isolated rat heart
reperfused after prolonged cardioplegia: A combined study
of metabolic, functional and morphometric ultrastructural
variables. Cardiovasc Res 1987;21:492-499
Garlick PB, Davies MJ, Hearse DJ, Slater TF: Direct detection of free radicals in the reperfused rat heart using electron
spin resonance spectroscopy. Circ Res 1987;61:757-760
Kramer JH, Arroyo CM, Dickens BF, Weglicki WB: Spintrapping evidence that graded myocardial ischemia alters
postischemic superoxide production. Free Radic Biol Med
1987;3:153-159
Ambrosio G, Zweier JL, Jacobus WE, Weisfeldt ML, Flaherty JT: Improvement of postischemic myocardial function
and metabolism induced by administration of desferrioxamine at the time of reflow: The role of iron in the pathogenesis
of reperfusion injury. Circulation 1987;76:906-915
Stewart JR, Blackwell WH, Crute SL, Loughlin V, Greenfield LJ, Hess ML: Inhibition of surgically induced ischemia/
735
II1):III-30-III-35
49. Homans DC, Sublett E, Dai XZ, Bache RJ: Persistence of
regional left ventricular dysfunction after exercise-induced
myocardial ischemia. J Clin Invest 1986;77:66-73
50. Gross GJ, Farber NE, Hardman HF, Warltier DC: Beneficial
actions of superoxide dismutase and catalase in stunned
myocardium of dogs. Am J Physiol 1986;250:H372-H377
51. O'Neill PG, Charlat ML, Hartley CJ, Roberts R, Bolli R:
Nonuniform transmural response of the "stunned" myocardium to inotropic stimulation (abstract). J Am Coll Cardiol
1987;9:145A
52. Preuss KC, Gross GJ, Brooks HL, Warltier DC: Time course
of recovery of "stunned" myocardium following variable
periods of ischemia in conscious and anesthetized dogs. Am
Heart J 1987;114:696-703
53. DeBoer FWV, Ingwall JS, Kloner RA, Braunwald E: Prolonged derangements of canine myocardial purine metabolism after a brief coronary artery occlusion not associated
with anatomic evidence of necrosis. Proc Natl Acad Sci USA
1980;77:5471-5475
54. Reimer KA, Hill ML, Jennings RB: Prolonged depletion of
ATP and of the adenine nucleotide pool due to delayed
resynthesis of adenine nucleotides following reversible myocardial ischemic injury in dogs. J Mol Cell Cardiol 1981;
13:229-239
55. Swain JL, Sabina RL, McHale PA, Greenfield JC Jr, Holmes
EW: Prolonged myocardial nucleotide depletion after brief
ischemia in the open-chest dog. Am J Physiol 1982;
242:H818-H826
56. Neely JR, Grotyohann LW: Role of glycolytic products in
damage to ischemic myocardium: Dissociation of adenosine
triphosphate levels and recovery of function of reperfused
ischemic hearts. Circ Res 1984;55:816-824
57. Przyklenk K, Kloner RA: Superoxide dismutase plus catalase
improve contractile function in the canine model of the
"stunned" myocardium. Circ Res 1986;58:148-156
58. Glower DD, Spratt JA, Newton JR, Wolfe JA, Rankin JS,
Swain JL: Dissociation between early recovery of regional
function and purine nucleotide content in postischaemic
myocardium in the conscious dog. Cardiovasc Res 1987;
21:328-336
59. Przyklenk K, Kloner RA: Effect of verapamil on postischemic
"stunned" myocardium: Importance of the timing of treatment. JAm Coll Cardiol 1988;11:614-623
60. Guth BD, Martin JF, Heusch G, Ross J Jr: Regional myocardial blood flow, function and metabolism using
phosphorus-31 nuclear magnetic resonance spectroscopy
during ischemia and reperfusion in dogs. J Am Coll Cardiol
1987;10:673-681
61. Mercier JC, Lando U, Kanmatsuse K, Ninomiya K, Meerbaum S, Fishbein MC, Swan HJC, Ganz W: Divergent effects
of inotropic stimulation on the ischemic and severely
depressed reperfused myocardium. Circulation 1982;66:
397-400
62. Ellis SE, Wynne J, Braunwald E, Henschke CI, Sandor T,
Kloner RA: Response of reperfusion-salvaged, stunned myocardium to inotropic stimulation. Am Heart J 1984;107:9-13
63. Arnold JMO, Braunwald E, Sandor T, Kloner RA: Inotropic
stimulation of reperfused myocardium with dopamine:
Effects on infarct size and myocardial function. J Am Coll
Cardiol 1985;6:1026-1034
64. Bolli R, Zhu WX, Myers ML, Hartley CJ, Roberts R:
Beta-adrenergic stimulation reverses postischemic myocar-
736
65.
66.
67.
68.
69.
70.
71.
72.
73.
74.
75.
76.
77.
78.
79.
80.
81.
82.
83.
84.
1988;63:351-360
108. Schrier GM, Hess ML: Quantitative identification of superoxide anion as a negative inotropic species. Am J Physiol
1988;24:H138-H143
109. DiGuiseppi J, Fridovich I: Oxygen toxicity in Streptococcus
sanguis: The relative importance of superoxide and hydroxyl
radicals. J Biol Chem 1982;257:4046-4051
110. Triana JF, Unisa A, Bolli R: Antioxidant enzymes attenuate
myocardial "stunning" in the conscious dog. FASEB J 1990;
4:A622
111. Zweier JL, Flaherty JT, Weisfeldt ML: Direct measurement
of free radical generation following reperfusion of ischemic
myocardium. Proc NatlAcad Sci USA 1987;84:1404-1407
112. Baker JE, Felix CC, Olinger GN, Kalyanaraman B: Myocardial ischemia and reperfusion: Direct evidence for free
radical generation by electron spin resonance spectroscopy.
Proc Natl Acad Sci USA 1988;85:2786-2789
113. Zweier JL: Measurement of superoxide-derived free radicals
in the reperfused heart. J Biol Chem 1988;263:1353-1357
114. Bolli R, McCay PB: Use of spin traps in intact animals
undergoing myocardial ischemia/reperfusion: A new
approach to assessing the role of oxygen radicals in myocardial "stunning." Free Rad Res Comms 1990;9:169-180
115. Bolli R, Patel BS, Jeroudi MO, Lai EK, McCay PB: Demonstration of free radical generation in "stunned" myocardium
of intact dogs with the use of the spin trap a-phenyl N-tertbutyl nitrone. J Clin Invest 1988;82:476-485
116. Leiboff RL, Arroyo CM, Schaer GL, Mergner GW, Kramer
JH, Miller DL, Visner MS, Weglicki WB: Free radical
generation in an in vivo model of regional myocardial stunning (abstract). FASEB J 1988;2:A818
117. Bolli R, Jeroudi MO, Patel BS, DuBose CM, Lai EK,
Roberts R, McCay PB: Direct evidence that oxygen-derived
free radicals contribute to postischemic myocardial dysfunction in the intact dog. Proc Natl Acad Sci USA 1989;
86:4695-4699
118. Burton KP, McCord JM, Ghai G: Myocardial alterations due
to free-radical generation. Am JPhysiol 1984;246:H776-H783
119. Blaustein AS, Schine L, Brooks WW, Fanburg BL, Bing
OHL: Influence of exogenously generated oxidant species on
myocardial function. Am J Physiol 1986;250:H595-H599
120. Shattock MJ, Manning AS, Hearse DJ: Effects of hydrogen
peroxide on cardiac function and postischaemic functional
recovery in the isolated "working" rat heart. Pharmacology
1982;24:118-122
121. Ytrehus K, Myklebust R, Mjos OD: Influence of oxygen
radicals generated by xanthine oxidase in the isolated per-
737
III):III-14-III-18
1984;55:120-124
02
Circulation 1987;76:678-686
139. Eddy LJ, Stewart JR, Jones HP, Engerson TD, McCord JM,
Downey JM: Free radical-producing enzyme, xanthine oxidase, is undetectable in human hearts. Am J Physiol 1987;
253:H709-H711
1986;548(suppl):39-46
Cardiol 1987;82:486-492
80(suppl II):II-295
145. Lucchesi BR, Mullane KM: Leukocytes and ischemiainduced myocardial injury. Ann Rev Pharmacol Toxicol 1986;
26:201-224
146. Engler R: Granulocytes and oxidative injury in myocardial
ischemia and reperfusion. Fed Proc 1987;46:2395-2396
738
147. Shea MJ, Simpson PJ, Werns SW, Buda AJ, AlborzyKhaghany AS, Hoff PT, Lucchesi BR: Effect of neutrophil
depletion on recovery of "stunned" myocardium (abstract).
Clin Res 1987;35:327A
148. Jeremy RW, Becker LC: Neutrophil depletion does not
prevent myocardial dysfunction after brief coronary occlusion. JAm Coll Cardiol 1989;13:1155-1163
149. O'Neill PG, Charlat ML, Kim H-S, Pocius J, Michael LH,
Hartley CJ, Roberts R, Bolli R: Lipoxygenase inhibitor
nafazatrom fails to attenuate postischemic ventricular dysfunction. Cardiovasc Res 1987;21:755-760
150. Schott RJ, Nao BS, McClanahan TB, Simpson PJ, Stirling
MC, Todd RF III, Gallagher KP: F(ab')2 fragments of
anti-mol (904) monoclonal antibodies do not prevent myocardial stunning. Circ Res 1989;65:1112-1124
151. Kerber RE, Shasby DM, Seabold J, Kieso R, Fox-Eastham K:
Does reduction of leukocyte accumulation in reperfused
myocardium affect stunning (abstract)? Circulation 1989;
80(suppl II):II-401
152. Go LO, Murry CE, Richard VJ, Jennings RB, Weischedel
GR, Reimer KA: Myocardial neutrophil accumulation during
reperfusion after reversible or irreversible ischemic injury.
Am J Physiol 1988;255:H1188-H1198
153. Engler RL, Dahlgren MD, Morris DD, Peterson MA,
Schmid-Schonbein GW: Role of leukocytes in response to
acute myocardial ischemia and reflow in dogs. Am J Physiol
1986;251:H314-H322
154. Engler R, Covell JW: Granulocytes cause reperfusion ventricular dysfunction after 15-minute ischemia in the dog. Circ
Res 1987;61:20-28
155. Westlin W, Mullane KM: Alleviation of myocardial stunning
by leukocyte and platelet depletion. Circulation 1989;
80:1828-1836
156. Kloner RA: Do neutrophils mediate the phenomenon of
The online version of this article, along with updated information and services, is located on
the World Wide Web at:
http://circ.ahajournals.org/content/82/3/723
Permissions: Requests for permissions to reproduce figures, tables, or portions of articles originally
published in Circulation can be obtained via RightsLink, a service of the Copyright Clearance Center, not the
Editorial Office. Once the online version of the published article for which permission is being requested is
located, click Request Permissions in the middle column of the Web page under Services. Further
information about this process is available in the Permissions and Rights Question and Answer document.
Reprints: Information about reprints can be found online at:
http://www.lww.com/reprints
Subscriptions: Information about subscribing to Circulation is online at:
http://circ.ahajournals.org//subscriptions/